REUTERS
Ukraine could receive an additional 8 million doses of a COVID-19 vaccine for free as part of the COVAX Facility, in addition to the already guaranteed 8 million. Thus, the total number of doses to be provided could reach 16 million.
This was announced by Ukraine s Chief Medical Officer Viktor Liashko in an interview for Radio NV.
He specified that an additional 8 million doses are still a potential opportunity. Ukraine could count on at least 8 million doses of the vaccine, that is, this is the calculated number of doses in accordance with 20% of the total population. We are continuing negotiations with them [the World Health Organization, WHO] to ensure more doses. Everything will depend on the total the cost of vaccines that fall into the COVAX portfolio. There is a potential possibility that Ukraine may be given 16 million doses through this facility – it s under discussion, but there are no guarantees yet. Eight million is a 100% guarantee, 16 [million] is a pot
REUTERS
Ukrainian diplomatic corps would be making every effort to make sure Ukraine receives the COVID-19 vaccine as soon as possible, says Mykhailo Radutsky, MP with the ruling Servant of the People parliamentary faction, Chairman of the Parliamentary Committee on National Health, Medical Assistance and Medical Insurance. According to the agreement signed with COVAX [the COVID-19 Vaccine Global Access Facility], Ukraine should receive 8 million doses. This is approximately 4 million vaccinated people in the first wave – these are those who are prioritized by government. These are healthcare workers, military, employees of the State Emergency Service, social workers, as well as the elderly accommodated in nursing homes, he told Ukraine 24 TV channel.
REUTERS
The U.S. Food and Drug Administration has granted an emergency use authorization for Moderna, Inc s COVID-19 vaccine, the second vaccine for the prevention of coronavirus disease 2019. The FDA statement came after the agency s vaccine advisory panel voted almost unanimously 20 in favor, with one abstention that the benefits of the highly effective vaccine outweighed its risks for people 18 years of age and older, The Washington Post wrote on December 18.
Read alsoUkraine has equipment for Pfizer, BioNTech vaccine – expert Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older, the FDA said on its website on December 18.
17:50, 19.12.20 World 435
The data available so far showed a comparable, high level of effectiveness in all age groups examined.
REUTERS
The Swiss Agency for Therapeutic Products (Swissmedic) has granted approval for the first Covid-19 vaccine in Switzerland, jointly produced by the American Pfizer and the German BioNTech. According to the data evaluated by the Swiss Agency for Therapeutic Products, the vaccination protection seven days after the second vaccination is over 90%. It is the world s first approval in an ordinary process, the Ukrainian media outlet European Pravda said on December 19, referring to the regulator s website.
Read alsoU.S. FDA authorizes Moderna COVID-19 vaccine for emergency useSwissmedic received an application for the approval of the coronavirus vaccine two months ago. The data available so far showed a comparable, high level of effectivenes